4 Ensemble Capital Teva- Pharmaceutical Industries Ltd. Trades
Ensemble Capital started to build up the position in Teva- Pharmaceutical Industries Ltd. in Q1 2013. Since then they sold 183 Thousand shares. The investor completely sold their stake between Q2 2013 and Q4 2013.
Avg closing price
Price range
Sold -39.1 Thousand shares
Q4 2013
Avg closing price
$39.38
Price range
$36.59
-
$41.70
Sold 57.6% shares (-53.1 Thousand shares)
Q3 2013
Avg closing price
$39.00
Price range
$37.43
-
$41.27
Sold 49.5% shares (-90.5 Thousand shares)
Q2 2013
Avg closing price
$38.94
Price range
$37.80
-
$40.23
New holding (+183 Thousand shares)
Q1 2013
Avg closing price
$38.59
Price range
$37.19
-
$41.06
News about Teva- Pharmaceutical Industries Ltd. - ADR and Ensemble Capital
Tracking David Abrams'' Abrams Capital Management Portfolio - Q4 2023 Update
David Abrams'' 13F portfolio value rises to $3.22B, while Meta Platforms and Teva Pharmaceutical witness stake reductions. Explore more here.
Marathon Capital Management Sells 2,500 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Marathon Capital Management reduced its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) by 10.6% during the 2nd quarter, according to the company...